Immune effects of relaxation during chemotherapy for ovarian cancer

被引:25
作者
Lekander, M
Furst, CJ
Rotstein, S
Hursti, TJ
Fredrikson, M
机构
[1] KAROLINSKA INST,DEPT CLIN NEUROSCI,STOCKHOLM,SWEDEN
[2] KAROLINSKA HOSP,RADIUM HEMMET,DEPT ONCOL,S-10401 STOCKHOLM,SWEDEN
[3] STOCKHOLMS SJUKHEM,DEPT ONCOL,STOCKHOLM,SWEDEN
[4] DANDERYD HOSP,DEPT GEN ONCOL,S-18288 DANDERYD,SWEDEN
[5] UPPSALA UNIV,DEPT CLIN PSYCHOL,UPPSALA,SWEDEN
关键词
psychoneuroimmunology; chemotherapy; ovarian cancer; relaxation; anticipatory symptom;
D O I
10.1159/000289133
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Psychological interventions, such as relaxation training, have been applied to strengthen resistance to disease. There is evidence that relaxation can modify immune parameters in healthy populations and in chemotherapy naive cancer patients. Methods: In this study, 22 patients receiving chemotherapy for ovarian cancer were allocated to relaxation training with a clinical psychologist or to a control group. After 2 months' training, blood was sampled 2 days before chemotherapy in the patients' homes, and at the hospital prior to treatment. Results: On average, the intervention group showed higher lymphocyte counts, and a tendency to higher white blood cell numbers as compared to the control group. No significant effects were found in proliferative responses to mitogen and natural killer cell activity after intervention. Relaxation training did not modify the magnitude of changes in immune variables between home samples and at the hospital in anticipation of treatment. Conclusion: The study suggests that relaxation training can positively affect immune parameters in cancer patients, even if training is performed during myelosuppressive therapy.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 52 条
[1]   PSYCHONEUROIMMUNOLOGY - INTERACTIONS BETWEEN THE NERVOUS-SYSTEM AND THE IMMUNE-SYSTEM [J].
ADER, R ;
COHEN, N ;
FELTEN, D .
LANCET, 1995, 345 (8942) :99-103
[2]   COGNITIVE BEHAVIORAL STRESS MANAGEMENT INTERVENTION BUFFERS DISTRESS RESPONSES AND IMMUNOLOGICAL CHANGES FOLLOWING NOTIFICATION OF HIV-1 SEROPOSITIVITY [J].
ANTONI, MH ;
BAGGETT, L ;
IRONSON, G ;
LAPERRIERE, A ;
AUGUST, S ;
KLIMAS, N ;
SCHNEIDERMAN, N ;
FLETCHER, MA .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1991, 59 (06) :906-915
[3]  
BONADONNA G, 1988, HDB MED ONCOLOGY
[4]  
BONGARTZ W, 1987, HYPNOS, V14, P52
[5]   ANTICIPATORY IMMUNE SUPPRESSION AND NAUSEA IN WOMEN RECEIVING CYCLIC CHEMOTHERAPY FOR OVARIAN-CANCER [J].
BOVBJERG, DH ;
REDD, WH ;
MAIER, LA ;
HOLLAND, JC ;
LESKO, LM ;
NIEDZWIECKI, D ;
RUBIN, SC ;
HAKES, TB .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1990, 58 (02) :153-157
[6]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[7]   CONDITIONED SIDE-EFFECTS INDUCED BY CANCER-CHEMOTHERAPY - PREVENTION THROUGH BEHAVIORAL TREATMENT [J].
BURISH, TG ;
CAREY, MP ;
KROZELY, MG ;
GRECO, FA .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1987, 55 (01) :42-48
[8]   ETIOLOGY AND TREATMENT OF THE PSYCHOLOGICAL SIDE-EFFECTS ASSOCIATED WITH CANCER-CHEMOTHERAPY - A CRITICAL-REVIEW AND DISCUSSION [J].
CAREY, MP ;
BURISH, TG .
PSYCHOLOGICAL BULLETIN, 1988, 104 (03) :307-325
[9]   HYPNOSIS AND RELAXATION IN THE MEDICALLY-ILL [J].
COVINO, NA ;
FRANKEL, FH .
PSYCHOTHERAPY AND PSYCHOSOMATICS, 1993, 60 (02) :75-90
[10]  
DILLMAN RO, 1984, CANCER, V53, P1484, DOI 10.1002/1097-0142(19840401)53:7<1484::AID-CNCR2820530710>3.0.CO